-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Cadrenal Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q2 2025.
- Cadrenal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $593K, a 207% increase year-over-year.
- Cadrenal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $2.2M, a 260% increase year-over-year.
- Cadrenal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.42M, a 99.8% increase from 2023.
- Cadrenal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $710K, a 23.5% decline from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)